Effect of a Targeted Notification and Clinical Support Pathway on Individuals With Left Ventricular Hypertrophy

NACompletedINTERVENTIONAL
Enrollment

648

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

June 28, 2024

Study Completion Date

October 1, 2024

Conditions
Hypertrophy, Left VentricularHypertensionCardiomyopathies
Interventions
OTHER

Intervention: Population Health Coordinator

After being notified of the finding of LVH in their patient, the population health coordinator will offer to schedule a dedicated visit for the provider and their patient to discuss this finding through a structured correspondence. Additionally, the population health coordinator will offer to coordinate 24-hour ambulatory blood pressure monitoring before or after the patient visit as part of the evaluation of LVH. Finally, for patients without established cardiovascular care and whose etiology of LVH remains undetermined, the population health coordinator will offer to coordinate a visit with a cardiologist to discuss the finding of LVH.

Trial Locations (1)

02115

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER